ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $53,491,000 | -12.5% | 1,323,445 | +24.5% | 0.04% | +5.1% |
| Q2 2015 | $61,158,000 | -4.7% | 1,062,757 | +5.5% | 0.04% | -2.5% |
| Q1 2015 | $64,142,000 | +11.8% | 1,007,482 | +8.4% | 0.04% | +14.3% |
| Q4 2014 | $57,382,000 | +170.4% | 929,458 | +70.1% | 0.04% | +169.2% |
| Q3 2014 | $21,219,000 | -9.9% | 546,562 | -20.0% | 0.01% | -18.8% |
| Q2 2014 | $23,546,000 | +44.9% | 683,574 | +81.8% | 0.02% | +33.3% |
| Q1 2014 | $16,250,000 | +14.2% | 376,102 | +5.0% | 0.01% | +20.0% |
| Q4 2013 | $14,230,000 | -48.2% | 358,222 | -51.1% | 0.01% | -50.0% |
| Q3 2013 | $27,475,000 | – | 733,093 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|